AML
Aberrations
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Adenocarcinoma
Advanced Nonsmall Cell Lung Cancer
American Cancer Society
Anchorage-independent Growth
Angiogenesis
Antitumor Activity
Antitumor Effect
Antitumor Effects
Bladder Cancer
Breakpoints
Breast
Breast Cancer
Breast Cancer Cells
Breast Cancer Patients
Breast Cancer Risk
Breast Cancer.
Breast Cancers
Breast Carcinoma
Breast Tumors
CGH
Cancer
Cancer Cell Lines
Cancer Cells
Cancer Center
Cancer Death
Cancer Incidence
Cancer Patients
Cancer Registry
Cancer Risk
Cancer Society
Cancer Survivors
Cancer Therapy
Cancer Tissues
Cancer.
Cancers
Carboplatin
Carcinogenesis
Carcinoma
Carcinoma Cell Lines
Carcinoma Cells
Cell Carcinoma
Cell Growth
Cell Lines
Cell Lung Cancer
Cell Lung Carcinoma
Cells.
Cervical Carcinoma
Chemotherapy
|
Chromosome Arm
Chromosome Band
Chromosome Translocations
Chronic Myeloid Leukemia
Cisplatin
Colon Cancer
Colon Cancers
Colorectal Cancer
Colorectal Carcinoma
Comparative Genomic Hybridization
Complete Response
CpG Islands
Current Study
Cytoreductive Surgery
Disease Progression
Disease Recurrence
Disease-free Survival
Docetaxel
Doxorubicin
Ductal Adenocarcinoma
EGFR
EGFR Mutations
End Results
Endometrial Carcinoma
Epidermal Growth Factor Receptor
Epithelial Ovarian Cancer
Expression Levels
Factor Receptor
GIST
Gastric Cancer
Gastric Cancer Patients
Gastric Carcinoma
Gastrointestinal Stromal Tumors
Gefitinib
Gemcitabine
Genomic Hybridization
Gliomas
Growth Factor Receptor
HCC
Hazard Ratio
Hematologic Toxicity
Hepatocellular Carcinoma
Human Cancers
Hypermethylation
II Study
IV Disease
Imatinib
Incidence Rates
Independent Prognostic Factor
Induction Chemotherapy
Invasion
Irinotecan
|
LOH
Leukemia
Lung Adenocarcinoma
Lung Cancer
Lung Cancer Cells
Lung Carcinoma
Lymph Node Metastasis
Lymph Node Status
Lymph Nodes
Lymphoblastic Leukemia
Lymphoma
Malignancy
Malignant Tumors
Mammography
Median Follow-up
Median Survival
Medulloblastoma
Melanoma
Metastases
Metastasis
Metastatic Disease
Methylation
Multivariate Analysis
Myeloid Leukemia
NSCLC
Neuroblastoma
Neutropenia
Node Metastasis
Node Status
Non-small Cell Lung Cancer
Nonsmall Cell Lung Cancer
Nude Mice
OS
Objective Response
Oncogenes
Oncol
Oncology
Osteosarcoma
Ovarian Cancer
Ovarian Carcinoma
Overexpression
PFS
Paclitaxel
Pancreatic Cancer
Pancreatic Cancer Cell Lines
Partial Response
Performance Status
Phase II Study
Poor Prognosis
Primary Tumor
Prognosis
Prognostic Factors
|
Prognostic Significance
Progression-free Survival
Promoter Hypermethylation
Promoter Methylation
Prostate Cancer
Prostate Carcinoma
RCC
Radiation Therapy
Radiotherapy
Renal Cell Carcinoma
Response Rate
SEER
Sarcoma
Sci
Small Cell Lung Cancer
Soft Tissue Sarcoma
Solid Tumors
Squamous Cell Carcinoma
Stable Disease
Stage I
Stromal Tumors
Suppressor Gene
Survival Rates
Survivors
Tissue Sarcoma
Tumor Cells
Tumor Development
Tumor Growth
Tumor Progression
Tumor Response
Tumor Samples
Tumor Size
Tumor Stage
Tumor Suppressor
Tumor Suppressor Gene
Tumor Tissue
Tumor Types
Tumorigenesis
Tumors
Tumors.
UICC
Vincristine
Wilms Tumor
Xenografts
|